GVR Report cover Biopharma Plastics Market Size, Share & Trends Report

Biopharma Plastics Market Size, Share & Trends Analysis Report By Polymer Type (Polyvinyl Chloride, Polyethylene), By Application (Syringes, Containers), By Region, And Segment Forecasts, 2022 - 2030

  • Report ID: GVR-4-68039-991-4
  • Number of Pages: 147
  • Format: Electronic (PDF)

Report Overview

The global biopharma plastics market size was valued at USD 4.34 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 11.2% from 2022 to 2030. Factors such as the increase in global healthcare expenditure and increasing cases of cancer across the globe are expected to boost the market growth in the forecast period.

 U.S. biopharma plastics market size, by polymer type, 2020 - 2030 (USD Million)

Biopharma plastics are widely utilized in the manufacturing of various healthcare applications such as protective wear, containers, syringes, disposable connectors, and bioreactor bags owing to their properties including thermal stability, low chemical reactivity, and high resistivity. Hence, polymer types such as polyethylene (PE), polypropylene (PP), acrylonitrile butadiene styrene (ABS), polyvinyl chloride (PVC), and polytetrafluoroethylene (PTFE) have witnessed a rise in the demand from the biopharma industry.

To cater to the increasing growth in the healthcare industry, biopharma plastics are being utilized for providing higher stability to several applications including depth filters, syringes, and containers. The market offers opportunities for the usage of a variety of polymer types such as PP, PE, PET, PTFE, and ABS as these polymer types are used for manufacturing biopharma plastic components including personal equipment (PPE), face masks, gloves, and gowns.

The effects of the spread of COVID-19 at the community level in the country in 2020 are projected to lead to an increased demand for various biopharma plastic-based products such as syringes, gloves, and masks resulting in the surging demand for biopharma plastics polymers. Polyvinyl chloride used in the production of containers, syringes, and others is likely to boost market growth across the globe over the forecast period.

Major players are continuously working on developing biopharma plastic components owing to the rising health concerns regarding the rise in several chronic diseases such as heart disease, cancer, diabetes, stroke, and arthritis. For instance, in June 2021, Celanese Corporation announced the acquisition of a contractual deal to acquire Exxon Mobil Corporation's Santoprene TPV elastomers division. Santoprene TPV materials are used in healthcare, biopharma, and medical devices including syringe tips, peristaltic tubes, seals, prosthetic cushions, tourniquets, dental and medical hoods, and masks.

Polymer Type Insights

Polyvinyl chloride (PVC) dominated the global market and accounted for more than 20.0% share of the overall revenue in 2021. Polyvinyl chloride has the ability to undergo many processes without breaking or cracking, which accounts for its multiple uses in the market. It is extremely flexible, resistant, and can easily withstand high temperatures, making it suitable for the production of syringes, disposable connectors, depth filters, and other applications of biopharma plastics.

Biopharma plastic polymers are used to provide a smooth durable finish having high resistance to UV and chemical exposure. Biopharma plastic polymers are also impressive for their oxidation resistance capacity, water-repellency with simultaneous vapor permeability, and outstanding mechanical properties, thus ensuring that the end product is durable, sustainable, and economic. The hydrophobic nature of biopharma polymers has led to the increased usage of biopharma plastics in protective wear in the healthcare industry.

Factors such as suitable demographics for production, increasing health concerns, and growth in healthcare expenditure are expected to drive the market for biopharma plastics along with polymers. Moreover, the presence of large-scale PP molding facilities and the manufacturing sector is projected to propel the market growth over the forecast period. Other polymer types such as polyethylene and polytetrafluoroethylene are mainly used in various applications owing to their properties such as gloss, durability, and detergent resistance. The aforementioned factors are likely to boost market growth over the forecast period.

Application Insights

Syringes dominated the market and accounted for more than 20.0% share in terms of revenue in 2021. Growth in the demand for prefilled syringes owing to their usage convenience, low costs, minimal microbial contamination, low injection errors, and dilution errors is expected to boost the growth of the market.

 Global biopharma plastics market share, by application, 2021 (%)

Additionally, the surging adoption of advanced healthcare technologies, the growing production of large molecules, and the rising expenditure for the development of advanced healthcare facilities are fueling the growth. The growth of this segment can be attributed to the ease of usage and convenience offered by disposable biopharma plastic syringes.

Regional Insights

Asia Pacific dominated the market in 2021 and accounted for a revenue share of more than 30.0%. China led the market in 2021, in terms of both volume and revenue. The demand for high-quality biopharma plastic devices and components from hospitals is increasing in emerging economies such as China, India, and Japan on account of the rising population and expenditure on healthcare. This is boosting the market growth in the region.

Biopharma Plastics Market Trends by Region

North America is expected to register a CAGR of 11.4% in terms of revenue over the forecast period on account of a halt in the healthcare industry in this region. The U.S. has been spearheading the demand for biopharma plastics in this region. The presence of key manufacturers of biopharma plastics such as Celanese Corporation, Eastman Chemical Co., and DuPont can be regarded as one of the leading factors driving the market in the country.

Key Companies & Market Share Insights

The market has been characterized by the presence of key players along with a few medium and small regional players. Major players are continuously working on developing polymers for the production of biopharma plastics owing to the rising demand for biopharma plastic components from the healthcare industry.

A majority of the global companies are expected to increase their polymer offerings to Asia Pacific, Central, and South America, and the Middle East and Africa owing to high market growth potential in these regions given the expansion of the biopharma plastics industry. Some prominent players in the global biopharma plastics market include:


  • LyondellBasell Industries Holdings B.V.


  • LG Chem

  • Toray Industries, Inc.

  • Solvay

  • Dow, Inc.

  • DuPont de Nemours, Inc.

  • Saint-Gobain Performance Plastics

  • Tekni-Plex

  • Chevron Phillips Chemical Co., LLC

  • Exxon Mobil Corporation

  • Formosa Plastics Corporation

  • Covestro AG


  • Mitsui & Co. Plastics Ltd.

  • INEOS Group


Biopharma Plastics Market Report Scope

Report Attribute


Market size value in 2022

USD 4.8 billion

Revenue forecast in 2030

USD 11.3 billion

Growth Rate

CAGR of 11.2% from 2022 to 2030

Base year for estimation


Historical data

2019 - 2020

Forecast period

2022 - 2030

Quantitative units

Volume in kilotons, revenue in USD million/billion, and CAGR from 2022 to 2030

Report coverage

Volume forecast, revenue forecast, competitive landscape, growth factors, and trends

Segments covered

Polymer type, application, region

Regional scope

North America; Europe; Asia Pacific; Central & South America; Middle East & Africa

Country scope

U.S.; Canada; Mexico; Germany; U.K.; France; Italy; China; India; Japan; Brazil; Argentina; GCC Countries; South Africa

Key companies profiled

BASF SE; LyondellBasell Industries Holdings B.V.; SABIC; LG Chem; Toray Industries, Inc.; Solvay; Dow, Inc.; DuPont de Nemours, Inc.; Saint-Gobain Performance Plastics; Tekni-Plex; Chevron Phillips Chemical Co., LLC; Exxon Mobil Corporation; Formosa Plastics Corporation; Covestro AG; TEIJIN LIMITED; Mitsui & Co. Plastics Ltd.; INEOS Group; CHIMEI

Customization scope

Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional, and segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options


Global Biopharma Plastics Market Segmentation

This report forecasts revenue and volume growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2030. For this study, Grand View Research has segmented the global biopharma plastics market report based on polymer type, application, and region:

Global Biopharma Plastics Market Segmentation

  • Polymer Type Outlook (Volume, Kilotons; Revenue, USD Million, 2019 - 2030)

    • Polyethylene (PE)

    • Polypropylene (PP)

    • Acrylonitrile Butadiene Styrene (ABS)

    • Polyethylene Terephthalate (PET)

    • Polyvinyl Chloride (PVC)

    • Polytetrafluoroethylene (PTFE)

    • Other

  • Application Outlook (Volume, Kilotons; Revenue, USD Million, 2019 - 2030)

    • Protective Wear

    • Containers

    • Bioreactor Bags

    • Syringes

    • Depth Filters

    • Disposable Medical Connectors

    • Others

  • Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2019 - 2030)

    • North America

      • U.S.

      • Canada

      • Mexico

    • Europe

      • Germany

      • U.K.

      • France

      • Italy

    • Asia Pacific

      • China

      • India

      • Japan

    • Central & South America

      • Brazil

      • Argentina

    • Middle East & Africa

      • GCC Countries

      • South Africa

Frequently Asked Questions About This Report

gvr icn


gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon